October 19, 2017 9:13 AM ET


Company Overview of MacroGenics, Inc.

Key Executives for MacroGenics, Inc.

NameBoard RelationshipsTitleAge
Scott Koenig M.D., Ph.D.30 RelationshipsChief Executive Officer, President and Director65
James Karrels No RelationshipsChief Financial Officer, Senior Vice President and Secretary50
Ezio Bonvini M.D.No RelationshipsChief Scientific Officer and Senior Vice President of Research63
Jeffrey Peters No RelationshipsActing General Counsel & VP of Legal Affairs--
Eric Blasius Risser No RelationshipsChief Business Officer and Senior Vice President of Business Development & Portfolio Management44
View More Key Executives

MacroGenics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Paulo F. Costa 20 RelationshipsMacroGenics, Inc.66
Scott Koenig M.D., Ph.D. 30 RelationshipsMacroGenics, Inc.65
Kenneth H. Galbraith C.A. 61 RelationshipsFive Corners Capital Inc.54
Matthew K. Fust 41 RelationshipsMacroGenics, Inc.52
Edward M. Hurwitz J.D. 45 RelationshipsMPM Capital54
View All Board Members

MacroGenics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee C.A.Kenneth H. Galbraith61 Relationships4 Executives
Compensation Committee Matthew K. Fust41 Relationships4 Executives
Nominating Committee Paulo F. Costa20 Relationships4 Executives
Corporate Governance Committee Paulo F. Costa20 Relationships4 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation$1.9M
Total Value of Options$535.6K
Compensation as of Fiscal Year 2016
MacroGenics, Inc. CEO Compensation
Industry Average


Tissue Regenix Group plc Announces Executive Changes
October 18, 2017 6:00 AM ET
Monash IVF Group Ltd. Announces the Appointment of David Morris as Chief Executive Officer and Managing Director, Effective 13 November 2017
October 17, 2017 10:12 PM ET
Dimerix Limited Appoints Medical Advisory Board
October 17, 2017 9:22 PM ET
Oncopeptides AB Appoints Nomination Committee in Respect of AGM 2018
October 17, 2017 2:00 PM ET
Gilead Sciences, Inc. Announces Promotion of Alessandro Riva to Executive Vice President, Oncology Therapeutics
October 17, 2017 12:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact MacroGenics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.